GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Jo-Jo Drugstores Inc (NAS:CJJD) » Definitions » ROE %

China Jo-Jo Drugstores (China Jo-Jo Drugstores) ROE % : -10.02% (As of Sep. 2023)


View and export this data going back to 2009. Start your Free Trial

What is China Jo-Jo Drugstores ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. China Jo-Jo Drugstores's annualized net income for the quarter that ended in Sep. 2023 was $-1.8 Mil. China Jo-Jo Drugstores's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $18.4 Mil. Therefore, China Jo-Jo Drugstores's annualized ROE % for the quarter that ended in Sep. 2023 was -10.02%.

The historical rank and industry rank for China Jo-Jo Drugstores's ROE % or its related term are showing as below:

CJJD' s ROE % Range Over the Past 10 Years
Min: -107.02   Med: -27.28   Max: 5.44
Current: -107.02

During the past 13 years, China Jo-Jo Drugstores's highest ROE % was 5.44%. The lowest was -107.02%. And the median was -27.28%.

CJJD's ROE % is ranked worse than
91.64% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.32 vs CJJD: -107.02

China Jo-Jo Drugstores ROE % Historical Data

The historical data trend for China Jo-Jo Drugstores's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Jo-Jo Drugstores ROE % Chart

China Jo-Jo Drugstores Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.00 -30.00 -35.05 -12.81 -100.43

China Jo-Jo Drugstores Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.04 -23.53 -5.02 -199.01 -10.02

Competitive Comparison of China Jo-Jo Drugstores's ROE %

For the Pharmaceutical Retailers subindustry, China Jo-Jo Drugstores's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Jo-Jo Drugstores's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Jo-Jo Drugstores's ROE % distribution charts can be found below:

* The bar in red indicates where China Jo-Jo Drugstores's ROE % falls into.



China Jo-Jo Drugstores ROE % Calculation

China Jo-Jo Drugstores's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=-21.139/( (24.085+18.014)/ 2 )
=-21.139/21.0495
=-100.43 %

China Jo-Jo Drugstores's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-1.848/( (18.014+18.885)/ 2 )
=-1.848/18.4495
=-10.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


China Jo-Jo Drugstores  (NAS:CJJD) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-1.848/18.4495
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.848 / 157.148)*(157.148 / 92.8695)*(92.8695 / 18.4495)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1.18 %*1.6921*5.0337
=ROA %*Equity Multiplier
=-2 %*5.0337
=-10.02 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-1.848/18.4495
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1.848 / -1.77) * (-1.77 / 0.512) * (0.512 / 157.148) * (157.148 / 92.8695) * (92.8695 / 18.4495)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0441 * -3.457 * 0.33 % * 1.6921 * 5.0337
=-10.02 %

Note: The net income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


China Jo-Jo Drugstores ROE % Related Terms

Thank you for viewing the detailed overview of China Jo-Jo Drugstores's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Jo-Jo Drugstores (China Jo-Jo Drugstores) Business Description

Traded in Other Exchanges
N/A
Address
386 Shangtang Road, Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Zhejiang Province, Hangzhou, CHN, 310008
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, Drug wholesale, and Herb farming. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
Executives
Wei Hu officer: Chief Operating Officer HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008
Pingfan Wu director HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008
Jiangliang He director HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY NY 310008
Liu Yan officer: Secretary HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY, ZHEJIANG PROVIN F4 310008
Lei Liu director, 10 percent owner, officer: CEO, Chairman of the Board ROOM 507-513, 5TH FLOOR,A BUILDING MEIDU PLAZA, GONGSHU DISTRICT HANGZHOU F4 310011
Ming Zhao director, 10 percent owner, officer: Chief Financial Officer 1ST FLOOR, YUZHENG PLAZA, NO. 76, YUHUANGSHAN ROAD, HANGZHOU, ZHEJIANG PROVINCE F4 00000
Caroline Wang director HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008
Hillhouse Investment Management, Ltd. 10 percent owner OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN E9 KY1-9006
Li Lei director, 10 percent owner, officer: CEO, Chairman of the Board 511 NE 94TH STREET MIAMI SHORES FL 33138
Li Qi director, 10 percent owner, officer: Secretary ROOM 507-513, 5TH FLOOR, A BUILDING MEIDU PLAZA, GONGSHU DISTRICT HANGZHOU F4 310011
Zhimin Su director 3601B THE CENTER, 989 CHANGLE ROAD SHANGHAI F4 200031
Genghua Gu director 1ST FLOOR, YUZHENG PLAZA NO.76, YUHUANGSHAN ROAD HANGZHOU, ZHEJIANG PROVINCE F4 310002
Taihong Guo director 7TH FLOOR, QINGCHUNBAO GROUP NO. 555 XIXI ROAD HANGZHOU F4 310013
Tchaikovsky Bennet Price Jr other: Former Director 11601 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90025
Marc Thomas Serrio other: Former Director P.O. BOX 91836 PASADENA CA 91109